Sugi Predict

Sugi Predict / Compounds / SCHEMBL3794403

SCHEMBL3794403

SCHEMBL3794403

CCC(=O)N1C(=O)C=CC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.47
▸ BLM P54132 3/20 0.47
▸ HPGD P15428 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ WRN Q14191 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ CES1 P23141 1/20 0.44
▸ MGLL Q99685 8/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ GMNN O75496 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ THPO P40225 1/20 0.44
▸ PMP22 Q01453 1/20 0.44
▸ GSK3A P49840 2/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ POLB P06746 1/20 0.39
▸ HTT P42858 3/20 0.37
▸ PTGS1 P23219 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18485449 0.81 CES1 (0.47) ALDH1A1BLMHPGDCYP1A2CYP2C19
SCHEMBL16234075 0.78 MGLL (0.44) ALDH1A1BLMHPGDCYP1A2CYP2C19
SCHEMBL4761585 0.77 MGLL (0.35) ALDH1A1BLMHPGDCYP1A2CYP2C19
SCHEMBL14363033 0.76 ALDH1A1 (0.36) ALDH1A1BLMHPGDCYP1A2CYP2C19
SCHEMBL22468787 0.76 PTGS1 (0.47) ALDH1A1CES1MGLLPOLBPTGS1
SCHEMBL8604468 0.76 TERT (0.39) ALDH1A1BLMHPGDCYP1A2CYP2C19
SCHEMBL8607093 0.75 MGLL (0.39) ALDH1A1BLMHPGDCYP1A2CYP2C19
SCHEMBL22468785 0.74 PTGS1 (0.50) ALDH1A1CES1MGLLPOLBPTGS1
SCHEMBL7738969 0.74 PTGS1 (0.50) ALDH1A1CES1MGLLPOLBPTGS1
SCHEMBL27524906 0.74 PTGS1 (0.50) ALDH1A1CES1MGLLPOLBPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216420-A1 HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF SEAGEN INC (US) 2024-07-04 — — US disclosed
US-11857565-B2 Hydrophobic Auristatin F compounds and conjugates thereof SEAGEN INC. (US) 2024-01-02 — — US disclosed
US-20230033133-A1 VACCINE CONJUGATES ULTIMOVACS AB (SE) 2023-02-02 — — US disclosed
EP-4069283-A1 VACCINE CONJUGATES Ultimovacs AB (SE) 2022-10-12 — — EP disclosed
CN-114901305-A Vaccine conjugates 乌尔蒂莫瓦科斯公司 2022-08-12 — — CN disclosed
CN-112955503-A Chloroprene rubber composition and vulcanized molded article 电化株式会社 2021-06-11 — — CN disclosed
WO-2021110989-A1 VACCINE CONJUGATES ULTIMOVACS AB (SE) 2021-06-10 — — WO disclosed
US-20170117588-A1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2017-04-27 — — US disclosed
EP-3131153-A1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE Sumitomo Seika Chemicals Co., Ltd. (JP) 2017-02-15 — — EP disclosed
US-20150057431-A1 COMPOSITIONS FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH ABNORMAL ANGIOGENESIS COVX TECHNOLOGIES IRELAND LTD (IE) 2015-02-26 — — US disclosed
US-8912148-B2 Methods of treating a disease or condition associated with abnormal angiogenesis COVX TECHNOLOGY IRELAND, LTD. (IE) 2014-12-16 — — US disclosed
US-8207353-B2 Poly(ethylene glycol) containing chemically disparate endgroups INTEZYNE TECHNOLOGIES, INC. (US) 2012-06-26 — — US disclosed
US-8207353-B2 Poly(ethylene glycol) containing chemically disparate endgroups INTEZYNE TECHNOLOGIES, INC. (US) 2012-06-26 — — US disclosed
US-20100297025-A1 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives GUERBET. 2010-11-25 — — US disclosed
US-20100280252-A1 POLY(ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS INTEZYNE TECHNOLOGIES (US) 2010-11-04 — — US disclosed
US-20100280252-A1 POLY(ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS INTEZYNE TECHNOLOGIES (US) 2010-11-04 — — US disclosed
US-7780953-B2 Compositions magnetic particles covered with gem-bisphosphonate derivatives GUERBET (FR) 2010-08-24 — — US disclosed
US-20040253181-A1 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives GUERBET (FR) 2004-12-16 — — US disclosed
WO-2001027628-A1 ANTIBIOTIC-METAL COMPLEXES IN THE DETECTION OF GRAM-NEGATIVE BACTERIA AND OTHER BIOLOGICAL ANALYTES OLSTEIN ALAN D (US) 2001-04-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280252-A1 POLY(ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS GNE, EPRS1, ALG1 ALDH1A1 2008/4885BLM 1345/4885HPGD 1134/4885
US-20100297025-A1 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives PHOSPHO1, SGMS2, PTEN ALDH1A1 4721/4885BLM 2123/4885HPGD 1409/4885
US-11857565-B2 Hydrophobic Auristatin F compounds and conjugates thereof MSN, AURKA, AURKC ALDH1A1 2389/4885BLM 2921/4885HPGD 4100/4885
US-20230033133-A1 VACCINE CONJUGATES KLK3, CD4, CD74 ALDH1A1 4572/4885BLM 1160/4885HPGD 3554/4885
US-20150057431-A1 COMPOSITIONS FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH ABNORMAL ANGIOGENESIS VEGFA, TIE1, TEK ALDH1A1 1018/4885BLM 4162/4885HPGD 1811/4885
US-20240216420-A1 HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF MSN, AURKA, AURKC ALDH1A1 2389/4885BLM 2921/4885HPGD 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.